UK-based graphene technology company Paragraf has announced the close of its £12.8 million (over $16 million USD ) Series A round led by Parkwalk. The round also included investment from IQ Capital Partners, Amadeus Capital Partners and Cambridge Enterprise, the commercialization arm of the University of Cambridge, as well as several angel investors. The funding will aim to see Paragraf’s first graphene-based electronics products reach the market, transitioning the company into a commercial, revenue-generating entity.
Paragraf sets out to deliver IP-protected graphene technology using standard, mass production scale manufacturing approaches, enabling step-change performance enhancements to today’s electronic devices. The company’s first sensor products have reportedly demonstrated order of magnitude operational improvements over today’s incumbents. Achieving large-scale, graphene-based production technology may enable next generation electronics, including vastly increased computing speeds, significantly improved medical diagnostics and higher efficiency renewable energy generation as well as currently unachievable products such as instant charging batteries and very low power, flexible electronics.
Dr Simon Thomas, CEO and Co-founder of Paragraf, said: This funding marks the start of the next phase in Paragraf’s growth. I am extremely proud of the young team at Paragraf who have collectively delivered the early strategy milestones with great skill. This next phase will allow Paragraf to make these truly game-changing technologies a reality. Paragraf is continually seeking like-minded collaborative development, production and commercial partners to accelerate the delivery of the many exciting electronics technology opportunities graphene has to offer.
Alastair Kilgour from Parkwalk commented: Parkwalk has been impressed by the strong progress the management and company have made since the seed round and is delighted to lead this funding round. We believe that Paragraf is well-equipped to deliver the unique benefits of graphene to their customers and licensees, which in turn will enable transformative products.